Document
PGR2018-00001, No. 1013-10 Exhibit - Fosamax Drug Label (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1013-10 Exhibit - Fosamax Drug Label (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1037-21 Exhibit - Annex 2 WHO good mfg practices for pharm prods main principles (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1037-21 Exhibit - Annex 2 WHO good mfg practices for pharm prods main principles (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1047-29 Exhibit - Bisphosphonates Potential therapeutic agents for disease modification in osteoarthritis (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1047-29 Exhibit - Bisphosphonates Potential therapeutic agents for disease modification in osteoarthritis (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1002-2 Exhibit - File History of US Patent No 9,539,268 (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1002-2 Exhibit - File History of US Patent No 9,539,268 (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1030-17 Exhibit - Eliminating the need for fasting with oral administration of bisphosphonates (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1030-17 Exhibit - Eliminating the need for fasting with oral administration of bisphosphonates (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1055-36 Exhibit - Prospective examination of pain related and psychological predictors of CRPS like phenomena following total knee arthroplasty a preliminary study (P.T.A...
Cite Document
PGR2018-00001, No. 1055-36 Exhibit - Prospective examination of pain related and psychological predictors of CRPS like phenomena following total knee arthroplasty a preliminary study (P.T.A.B. Oct. 10
+ More Snippets
Document
PGR2018-00001, No. 1009-8 Exhibit - Leonard (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1009-8 Exhibit - Leonard (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1003-3 Exhibit - Declaration of Stephen Bruehl, PhD (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1003-3 Exhibit - Declaration of Stephen Bruehl, PhD (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1081-56 Exhibit - Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema the Zoledronic Acid in Psoriatic Arthritis Study (P.T.A.B....
Cite Document
PGR2018-00001, No. 1081-56 Exhibit - Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema the Zoledronic Acid in Psoriatic Arthritis Study (P.T.A.B. Oct. 10, 201
+ More Snippets
Document
PGR2018-00001, No. 1048-30 Exhibit - Effect of risedronate on joint structure and symptoms of knee osteoarthritis results of the BRISK randomized, controlled trial (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1048-30 Exhibit - Effect of risedronate on joint structure and symptoms of knee osteoarthritis results of the BRISK randomized, controlled trial (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1083-58 Exhibit - Characterisation of a Freunds complete adjuvant induced model of chronic arthritis in mice (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1083-58 Exhibit - Characterisation of a Freunds complete adjuvant induced model of chronic arthritis in mice (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1056-37 Exhibit - Development of a severity score for CRPS (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1056-37 Exhibit - Development of a severity score for CRPS (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1027-14 Exhibit - Intl Patent App Pub No WO2011014781 (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1027-14 Exhibit - Intl Patent App Pub No WO2011014781 (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1063-40 Exhibit - Chapter 3 Pharmacokinetics in Modern Pharm (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1063-40 Exhibit - Chapter 3 Pharmacokinetics in Modern Pharm (P.T.A.B. Oct. 10, 2017)
+ More Snippets
Document
PGR2018-00001, No. 1033-18 Exhibit - MER 101 tablets A pilot bioavailability study of a novel oral formulation of zoledronic acid (P.T.A.B. Oct. 10, 2017)
Cite Document
PGR2018-00001, No. 1033-18 Exhibit - MER 101 tablets A pilot bioavailability study of a novel oral formulation of zoledronic acid (P.T.A.B. Oct. 10, 2017)
+ More Snippets